These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18345329)

  • 1. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.
    Asselbergs FW; van den Berg MP; Bakker SJ; Signorovitch JE; Hillege HL; van Gilst WH; van Veldhuisen DJ
    Neth Heart J; 2008; 16(3):73-8. PubMed ID: 18345329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
    Wachter R; Lahno R; Haase B; Weber-Krüger M; Seegers J; Edelmann F; Wohlfahrt J; Gelbrich G; Görlitz A; Kermer P; Vollmann D; Hasenfuß G; Gröschel K; Stahrenberg R
    PLoS One; 2012; 7(4):e34351. PubMed ID: 22509292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
    Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
    Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
    Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
    ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study.
    Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Frikke-Schmidt R; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH
    Circulation; 2023 Jun; 147(24):1788-1797. PubMed ID: 37061802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
    Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
    Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: the Hisayama Study.
    Nagata T; Hata J; Sakata S; Oishi E; Honda T; Furuta Y; Ohara T; Yoshida D; Hirakawa Y; Shibata M; Ide T; Kitazono T; Tsutsui H; Ninomiya T
    Int J Cardiol; 2020 Dec; 320():90-96. PubMed ID: 32592745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation.
    Bai M; Yang J; Li Y
    Clin Cardiol; 2009 Dec; 32(12):E1-5. PubMed ID: 20014208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
    Kerr B; Brandon L
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection.
    Gurgo AM; Ciccone AM; D'Andrilli A; Ibrahim M; Musumeci B; Quarta G; Saponaro A; Rendina EA; Volpe M
    Minerva Cardioangiol; 2008 Dec; 56(6):581-5. PubMed ID: 19092733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
    Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population.
    Ulimoen SR; Enger S; Tveit A
    Scand J Clin Lab Invest; 2009; 69(5):579-84. PubMed ID: 19391062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.